
Rakuten Medical, Inc. has raised $225.9M in total funding. The most recent round was Series F.
Rakuten Medical, Inc. is headquartered in San Diego, CA.
Cancer patients need better treatment options, regardless of nationality or wealth, and existing care can come too late, as described in the Executive Chairman's personal letter about his father.
Rakuten Medical is developing drugs and devices based on its investigational Alluminox platform to bring new cancer treatments to market.
Their core technology is photoimmunotherapy under the Alluminox platform, originally developed by Dr. Hisataka Kobayashi and team at the U.S. National Cancer Institute, with their lead candidate ASP-1929 presenting new clinical data at conferences like ASCO and AHNS.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.